AI and the Pharmaceutical Industry — Weekly 2026-W40
This page is a mechanical aggregation of the daily data and carries no commentary. See the daily pages for interpretation.
💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
🧬 Drug Discovery3
- S3 Capital moveShionogi, with AI drug discovery, halves time to clinical trials to 3 years; leverages talent from JT's pharmaceutical business acquisition — 日本経済新聞10/01 05:00 JST
- S2 Deal / PartnershipHansa Biopharma Partners With Cradle To Advance AI-Driven Protein Design And Engineering — TradingView10/01 15:02 JST
- S1 DeploymentAI Drug Discovery Forecasts Vary Widely as Sector Shifts to Deployment — PR Newswire10/02 01:11 JST
🧪 Clinical Development2
- S4 Amount disclosedRoche Pours $2.4 Billion into Autonomous AI Lab as Phase III Success Rate Jumps to 80%$2.4 Billion — finance.biggo.com09/30 14:25 JSTRoche
- S2 Deal / PartnershipAbbVie Inc. (ABBV) Partners With Valkai to Apply AI in Clinical Development — TradingView09/29 22:00 JSTAbbVieAlso reported by 1: marketscreener.com
📑 CTD / Regulatory Submission1
- S3 Capital moveTransPerfect Acquires Synterex to Expand Medical Writing Expertise and AI-Enabled Regulatory Solutions — PR Newswire10/01 22:02 JST
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain0
No items today · See past 90 days →
✅ GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources0
No items today · See past 90 days →
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance6
- S4 Amount disclosedRoche invests $2.4 billion to build an AI-driven autonomous lab; Phase 3 clinical trial success rate jumps to 80%$2.4 billion — BigGo ファイナンス09/30 14:25 JST
- S4 Amount disclosedOrtet launches with $500 million commitment for healthcare AI$500 million — The Pharma Letter10/01 01:19 JST
- S1 DeploymentServier Adopts Veeva OpenData Globally to Scale AI — Morningstar09/30 20:03 JSTServierVeeva
- S4 Amount disclosedAI Is Reshaping Gene Transfer Technologies — $258.7 Billion in VC Signals a Structural Shift in Biotech Investment$258.7 Billion — GlobeNewswire10/01 22:38 JST
- S2 Deal / PartnershipCellCarta and Imagene AI Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development — PR Newswire10/01 22:15 JSTAlso reported by 1: Unite.AI
- S2 Deal / PartnershipRakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development — biospace.com10/01 21:02 JST